These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25393311)

  • 41. Pay for Performance and Treatment Outcome in Agonist Treatment for Opioid Use Disorder.
    Loscalzo E; Levit A; Sterling RC; Weinstein SP
    Am J Addict; 2021 Mar; 30(2):173-178. PubMed ID: 33002304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada: A Randomized Clinical Trial.
    Spithoff S; Mogic L; Hum S; Moineddin R; Meaney C; Kiran T
    JAMA Netw Open; 2022 Sep; 5(9):e2233659. PubMed ID: 36178686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Web-Based Behavior Therapy Program Influences the Association Between Cognitive Functioning and Retention and Abstinence in Clients Receiving Methadone Maintenance Treatment.
    Acosta MC; Marsch LA; Xie H; Guarino H; Aponte-Melendez Y
    J Dual Diagn; 2012 Oct; 8(4):283-293. PubMed ID: 23671409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initiation and engagement as mechanisms for change caused by collaborative care in opioid and alcohol use disorders.
    Setodji CM; Watkins KE; Hunter SB; McCullough C; Stein BD; Osilla KC; Ober AJ
    Drug Alcohol Depend; 2018 Nov; 192():67-73. PubMed ID: 30223190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial.
    Giang LM; Trang NT; Diep NB; Thuy DTD; Thuy DT; Hoe HD; Van HTH; Truc TT; Nguyen HH; Lai NL; Linh PTD; Vi VTT; Reback CJ; Leibowitz A; Li L; Lin C; Li M; Do Van Dung ; Shoptaw S
    Trials; 2022 Apr; 23(1):342. PubMed ID: 35461300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using ADAPT-ITT framework to tailor evidence-based interventions for addressing methamphetamine use among methadone patients in Vietnam.
    Giang LM; Trang NT; Thuy DT; Nguyen HH; Diep NB; Van HTH; Truc TT; Reback CJ; Li M; Van Dung D; Shoptaw S
    Drug Alcohol Rev; 2023 Nov; 42(7):1667-1679. PubMed ID: 37614129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interim versus standard methadone treatment: a benefit-cost analysis.
    Schwartz RP; Alexandre PK; Kelly SM; O'Grady KE; Gryczynski J; Jaffe JH
    J Subst Abuse Treat; 2014 Mar; 46(3):306-14. PubMed ID: 24239030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methadone treatment in medical private practice: outcome according to the number of courses followed.
    Meystre-Agustoni G; Wietlisbach V; Martin J; Haller-Maslov E
    Br J Addict; 1990 Apr; 85(4):537-45. PubMed ID: 2346793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The need to broaden and strengthen the evidence base for supervised consumption sites.
    May T; Holloway K; Bennett T
    Addiction; 2019 Dec; 114(12):2117-2118. PubMed ID: 31496003
    [No Abstract]   [Full Text] [Related]  

  • 50. Review: methadone dose reduction is better than alpha2 adrenergic agonists for treatment retention in opioid dependence.
    Yu E
    Evid Based Ment Health; 2002 Aug; 5(3):81. PubMed ID: 12180448
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
    Hser YI; Evans E; Huang D; Weiss R; Saxon A; Carroll KM; Woody G; Liu D; Wakim P; Matthews AG; Hatch-Maillette M; Jelstrom E; Wiest K; McLaughlin P; Ling W
    Addiction; 2016 Apr; 111(4):695-705. PubMed ID: 26599131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver enzyme levels in adolescent patients treated with buprenorphine and additional psychotropic agents.
    Ciftci Demirci A; Gunes H; Adaletli H; Bulanik E; Erdogan A
    Am J Drug Alcohol Abuse; 2015 Jan; 41(1):107-13. PubMed ID: 25490611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges of methadone maintenance treatment decentralisation from Vietnamese primary care providers' perspectives.
    Nguyen DB; Nguyen TT; Lin C; Dinh TTT; Le GM; Li L
    Drug Alcohol Rev; 2023 May; 42(4):803-814. PubMed ID: 36851865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study).
    Rolland B; Lions C; Di Beo V; Carrieri P; Authier N; Barré T; Delorme J; Mathurin P; Bailly F; Protopopescu C; Marcellin F
    Harm Reduct J; 2022 Oct; 19(1):119. PubMed ID: 36303159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.
    McCarty D; Bougatsos C; Chan B; Hoffman KA; Priest KC; Grusing S; Chou R
    Am J Psychiatry; 2021 Sep; 178(9):804-817. PubMed ID: 34315284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective Study on Factors Associated with Referral of Patients with Opioid Maintenance Therapy from Specialized Addictive Disorders Centers to Primary Care.
    Guillou-Landreat M; Levassor P; Guerlais M; Sebille V; Victorri-Vigneau C
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071908
    [No Abstract]   [Full Text] [Related]  

  • 58. Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.
    Hill K; Nussdorf L; Mount JD; Silk R; Gross C; Sternberg D; Bijole P; Jones M; Kier R; Mccullough D; Mathur P; Kottilil S; Masur H; Kattakuzhy S; Rosenthal ES
    J Addict Med; 2022 Jan-Feb 01; 16(1):10-17. PubMed ID: 33560694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treating opioid use disorder in primary care.
    Perry D; Orrantia E; Garrison S
    Can Fam Physician; 2019 Feb; 65(2):117. PubMed ID: 30765361
    [No Abstract]   [Full Text] [Related]  

  • 60. Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment.
    Dunlap LJ; Zarkin GA; Orme S; Meinhofer A; Kelly SM; O'Grady KE; Gryczynski J; Mitchell SG; Schwartz RP
    J Subst Abuse Treat; 2018 Nov; 94():81-90. PubMed ID: 30243422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.